BALLERUP, Denmark and REDWOOD CITY, Calif., Feb. 10, 2025 /PRNewswire/ -- Norlase today announced the appointment of Jacob Philipsen, CEO of Advalight and co-founder of Norlase, as the new Chairman ...
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
Healthcare stocks have jumped, but the easy money has already been made. The ETF, home to health insurers, drugmakers, and ...
Sundance 2025 might be over, but these are some of the films that people will be talking about these films for the rest of ...
“We are pleased to welcome Jesse to the Axogen team," said Michael Dale, Chief Executive Officer, and Director, Axogen. "His extensive experience in regulatory strategy and deep understanding of the ...
Axogen (AXGN) announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs. Bishop will report to Michael Dale, President, ...
The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it ...
Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools that ...
The World Health Organization (WHO) congratulates Guinea for eliminating the gambiense form of human African trypanosomiasis ...
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...
Ms Badolé suffers from loiasis, a chronic filarial disease caused by the Loa loa parasite, also known as the African eye worm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results